Trial Search Results

Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Santa Clara Valley Health & Hospital System

Stanford Investigator(s):

Intervention(s):

  • Device: Continuous Glucose Monitor

Eligibility


Inclusion Criteria:

- Pregnant patients under 28 weeks gestation

Exclusion Criteria:

- Pre-gestational diabetes

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Yasser El-Sayed
6507233198
Not Recruiting